Crossmark

Interference KRT17 reverses doxorubicin resistance in triple-negative breast cancer cells by Wnt/β-catenin signaling pathway

Published Online: 2023-08-27

Published Print: 2023-10

Authors

Wu, Liqiong

Ding, Wenshuang

Wang, Xiaopai

Li, Xiubo

Yang, Jing
License Information

Text and Data Mining valid from 2023-08-27

Version of Record valid from 2023-08-27
More Information

Article History

Received: 25 April 2023

Accepted: 2 August 2023

First Online: 27 August 2023

Declarations

:

: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Document is current